IGFBP2 and neoplasm: Additionally, in 2016, following delineation in breast cancer, Patil et al. showed that the association between the arginine–glycine–aspartate (RGD) domain of IGFBP-2 and integrins could lead to the stabilisation of nuclear β-catenin, contributing to tumour growth [217,218].